[go: up one dir, main page]

DK84691D0 - Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater - Google Patents

Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater

Info

Publication number
DK84691D0
DK84691D0 DK91846A DK84691A DK84691D0 DK 84691 D0 DK84691 D0 DK 84691D0 DK 91846 A DK91846 A DK 91846A DK 84691 A DK84691 A DK 84691A DK 84691 D0 DK84691 D0 DK 84691D0
Authority
DK
Denmark
Prior art keywords
therapy
cells
methods
cellipols
glycolipides
Prior art date
Application number
DK91846A
Other languages
English (en)
Inventor
Karsten Buschard
Original Assignee
Karsten Buschard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karsten Buschard filed Critical Karsten Buschard
Priority to DK91846A priority Critical patent/DK84691D0/da
Publication of DK84691D0 publication Critical patent/DK84691D0/da
Priority to ES92910435T priority patent/ES2125898T3/es
Priority to JP51038492A priority patent/JP3222465B2/ja
Priority to AU17888/92A priority patent/AU1788892A/en
Priority to PCT/DK1992/000146 priority patent/WO1992019633A1/en
Priority to EP92910435A priority patent/EP0584175B1/en
Priority to AT92910435T priority patent/ATE175203T1/de
Priority to DK92910435T priority patent/DK0584175T3/da
Priority to DE69228061T priority patent/DE69228061T2/de
Priority to US08/396,802 priority patent/US5827828A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91846A 1991-05-07 1991-05-07 Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater DK84691D0 (da)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DK91846A DK84691D0 (da) 1991-05-07 1991-05-07 Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
ES92910435T ES2125898T3 (es) 1991-05-07 1992-05-07 Glicolipidos sulfatados que contienen un resto de galactosa-3-0-sulfato, y captadores especificos para los mismos, para uso en profilaxis o terapia de prediabetes, diabetes y/o complicaciones asociadas en un individuo.
JP51038492A JP3222465B2 (ja) 1991-05-07 1992-05-07 個体の糖尿病前症、糖尿病および／または関連合併症の予防または治療に用いる、ガラクトース−３−０−サルフェート部分を含有する硫酸化糖脂質類およびその特異的キャッチャー
AU17888/92A AU1788892A (en) 1991-05-07 1992-05-07 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
PCT/DK1992/000146 WO1992019633A1 (en) 1991-05-07 1992-05-07 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
EP92910435A EP0584175B1 (en) 1991-05-07 1992-05-07 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
AT92910435T ATE175203T1 (de) 1991-05-07 1992-05-07 Sulfatierte glykolipide, die eine galaktose-3-0- sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum
DK92910435T DK0584175T3 (da) 1991-05-07 1992-05-07 Sulfaterede glycolipider, der indeholder en galactose-3-0-sulfatdel, og specifikke fangere dertil til anvendelse i profylak
DE69228061T DE69228061T2 (de) 1991-05-07 1992-05-07 Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum
US08/396,802 US5827828A (en) 1991-05-07 1995-02-28 Sulfated glycolipids and antibodies thereto for prophylaxis or therapy of diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91846A DK84691D0 (da) 1991-05-07 1991-05-07 Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater

Publications (1)

Publication Number Publication Date
DK84691D0 true DK84691D0 (da) 1991-05-07

Family

ID=8098211

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91846A DK84691D0 (da) 1991-05-07 1991-05-07 Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
DK92910435T DK0584175T3 (da) 1991-05-07 1992-05-07 Sulfaterede glycolipider, der indeholder en galactose-3-0-sulfatdel, og specifikke fangere dertil til anvendelse i profylak

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92910435T DK0584175T3 (da) 1991-05-07 1992-05-07 Sulfaterede glycolipider, der indeholder en galactose-3-0-sulfatdel, og specifikke fangere dertil til anvendelse i profylak

Country Status (9)

Country Link
US (1) US5827828A (da)
EP (1) EP0584175B1 (da)
JP (1) JP3222465B2 (da)
AT (1) ATE175203T1 (da)
AU (1) AU1788892A (da)
DE (1) DE69228061T2 (da)
DK (2) DK84691D0 (da)
ES (1) ES2125898T3 (da)
WO (1) WO1992019633A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580858A (en) * 1991-06-10 1996-12-03 Alberta Research Council Immunosuppressive and tolerogenic modified Lewisx compounds
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
SE9601817D0 (sv) * 1996-05-13 1996-05-13 Karsten Buschard Novel glycolipid complexex and their uses
CN1768759A (zh) * 1997-04-10 2006-05-10 麒麟麦酒株式会社 神经酰胺化合物在制备细胞活化剂中的应用
EP1049477A1 (en) * 1997-12-30 2000-11-08 A+ Science Invest AB Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
SE0000258D0 (sv) * 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
CA2459482C (en) * 2001-08-16 2010-09-28 Daiichi Suntory Pharma Co., Ltd. Novel glycolipid and medicine for autoimmune disease containing the same as active ingredient
EP2040541B1 (en) 2006-06-30 2016-03-23 The Scripps Research Institute Adjuvants and methods of use
FR2926972B1 (fr) * 2008-02-05 2011-03-11 Technologia Appareil de diagnostic precoce du syndrome du canal carpien et procede et dispositif d'acquisition de l'information relative a la sensibilite cutanee du doigt du patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288706A (en) * 1987-12-25 1994-02-22 Mitsui Toatsu Chemicals, Incorporated Medicament for prevention and remedy of diseases of the pancreas and others

Also Published As

Publication number Publication date
DE69228061D1 (de) 1999-02-11
ATE175203T1 (de) 1999-01-15
EP0584175A1 (en) 1994-03-02
US5827828A (en) 1998-10-27
ES2125898T3 (es) 1999-03-16
DK0584175T3 (da) 1999-08-30
AU1788892A (en) 1992-12-21
DE69228061T2 (de) 1999-05-27
JPH06506943A (ja) 1994-08-04
JP3222465B2 (ja) 2001-10-29
EP0584175B1 (en) 1998-12-30
WO1992019633A1 (en) 1992-11-12

Similar Documents

Publication Publication Date Title
DK84691D0 (da) Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
Weinshilboum et al. Serum dopamine-beta-hydroxylase activity
DK120184A (da) Materiale og middel til detektering af naervaerelsen af et peroxidativt aktivt stof i en testproeve, samt fremstilling og anvendelse deraf
EP0370274A3 (en) Personal computer/host emulation system for handling host data with personal computer application programs at personal computers
GB1284476A (en) Potassium ion sensitive electrode
Costa et al. Elastic buckling of plates using the boundary element method
JPS52126136A (en) Disfigurement detecting system using figure outline information
Clausen et al. Thyroid Hormone Binding Proteins in Human Serum Characterized by Immuno-Electrophoresis and Auto-Radiographic Tracings.
NO920624L (no) Reagens for paavisning av fibrinolytisk aktivitet
Lagrue et al. Idiopathic cyclic edema. The role of capillary hyperpermeability and its correction by Ginkgo biloba extract
Chang et al. Reaction of concanavalin A with alkaline phosphatases extracted from various human tissue sources
Self et al. A new sensitive and fast peptide immunoassay based on enzyme amplification used in the determination of CGRP and the demonstration of its presence in the thyroid
Sato et al. The influence of normal human IgG and of thyroid-stimulating antibody (TSAb) on the binding of thyrotropin to thyroid plasma membranes
Zinder et al. Direct evidence for co-localization of adenylate cyclase, dopamine-β-hydroxylase and cytochrome b562 to bovine chromaffin granule membranes
DK116487A (da) Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.
Habior Effect of captopril on glutathione level in the liver and paracetamol-induced liver damage in rats
Myers et al. Hemoglobin adducts of benzo [a] pyrene in tobacco smokers: characterization of benzo [a] pyrene adducts in maternal and fetal blood samples
Iannone et al. Taxol inhibits N-formyl-methionyl-leucyl-phenylalanine (FMLP)-induced human neutrophil polarization and H 2 O 2 production while decreasing [3 H] FMLP binding
SE7705987L (sv) Referensmaterial for att uppretthalla anjonkoncentrationer vid analytiska kemiska tester, samt framstellning och anvendning derav
Brown Surface analysis of materials by static SIMS and FABMS.
Bakay et al. Effects of thalidomide and chlorcyclizine on the biosynthesis of nucleic acids and proteins in fetal and maternal tissues of the rat
Lu Solution of elastoplastic contact problem by boundary element method and mathematical programming technique
Bonilla et al. Serum enzyme activities following administration of purified basic proteins from rattlesnake venoms
LIEBOWITZ Fracture mechanics of aircraft structures(proceedings of conference on structural characteristics of aircraft components)
Goodman et al. Specificity of the action of parathyroid hormone upon mitochondrial metabolism: Cyanogen bromide-derived parathyroid-hormone peptides

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment